A Phase II Study of Ibrutinib With R-ICE Chemotherapy for Transplant-eligible Relapsed/Refractory Diffuse Large B-cell Lymphoma Followed by Ibrutinib Maintenance in Patients Not Achieving a Complete Response at Pre-transplant Interim Assessment
Latest Information Update: 04 Aug 2023
Price :
$35 *
At a glance
- Drugs Ibrutinib (Primary) ; Carboplatin; Etoposide; Ifosfamide; Rituximab
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 13 Feb 2017 Status changed from not yet recruiting to recruiting.
- 11 Nov 2016 New trial record